Evidence from systematic literature review

Overview of available vaccine types

Vaccine type	Number of references	Investigated species	Reference ID
Inactivated (dead)	24	Chickens, Ducks, Turkeys	50270, 50277, 50289, 50324, 50331, 50344, 50347, 50368, 50386, 50407, 50434, 50450, 50456, 50472, 50477, 50482, 50511, 50567, 50611, 50620, 50715, 50721, 50728, 54260
Live attenuated	2	Chickens	50376, 54260
Live recombinant	14	Chickens, Ducks, Turkeys	50277, 50281, 50305, 50318, 50385, 50386, 50397, 50434, 50435, 50440, 50447, 50472, 50477, 50489
Recombinant (subunit vaccines)	6	Chickens, Ducks, Turkeys	50265, 50327, 50335, 50385, 50397, 50629

Vaccine efficacy

The figure below presents all the results from studies in which the efficacy was actually reported. The number of occurrences for each vaccine type is reported in square brackets. Please note that the range of values might refer to different target species.

Summary of available data

Below you can find a summary of the main features of each study:

• RefID: Reference ID (to be used to retrieve full reference below)
  
• Species: in which animal species the diagnostic assays have been tested
  
• Vaccine type: Inactivated (dead), Live attenuated, Live recombinant, Recombinant (subunit vaccines), Other
  
• Country: country where study was conducted
• Nr tested: number of animals tested within the study. When multiple groups were tested, the range of animals per study group is reported
  
• Challenge day: number of days after vaccination at which animals were challenged. When multiple groups were challenged, the range of days post vaccination is reported
  
• Efficacy: whether an estimate of vaccine efficacy was reported in the article
   

REFERENCES

In the left panel you can find information about the entire systematic literature review. The specific references for this agent, and used in this section of the disease profiles are listed below.